Global estimates show that 5.2% of adults suffer from depression, a condition marked by persistent depressed mood or a loss of interest in activities. While many patients respond to standard medications, some continue experiencing symptoms, prompting a closer look at specialized interventions like repetitive transcranial magnetic stimulation.
Depression Affects 322 Million People Globally
Approximately 322 million people live with depressive disorder, a condition estimated to affect 5.2% of adults worldwide. In 2023, rates were 6.2% among women and 4.1% among men, making the illness about 1.5 times more common in women. Rates climb to 5.4% for adults aged 70 years and older, while more than 10% of pregnant women and new mothers experience depression worldwide.
Diagnostic criteria require symptoms to last most of the day, nearly every day, for at least two weeks. Manifestations include ongoing melancholy, a lack of interest in past hobbies, sleep disturbances, tiredness, trouble focusing, and dietary shifts. Physical signs include disrupted sleep, changes in appetite or weight, and profound fatigue, all of which can hinder a person’s capacity for labor, social bonds, and daily chores.
Standard Medications Fail Some Patients
A clinical hurdle persists when standard medications fail to resolve a patient’s condition.
Priya (name changed), a 32-year-old woman from Kerala, faced repeated bouts of depression that hampered her daily routine. Because her symptoms refused to go away, she pursued further clinical guidance and has begun treatment with repetitive transcranial magnetic stimulation (rTMS). Experts say Priya’s experience reveals a challenge in managing depression; even though antidepressants work for numerous individuals, certain patients persist in showing symptoms regardless of therapy, forcing clinicians to re-evaluate the diagnosis and look into alternative treatments.
Clinicians Use Brain Stimulation and Therapy
Psychological treatments serve as the primary response for depression, often combined with antidepressant medicines for moderate and severe cases. These treatments—which are not needed for mild depression—can include talk therapy with professionals or supervised lay therapists, delivered in person or online. Patients may also access care through self-help manuals, websites and apps to learn new ways of thinking, coping or relating to others.
Patients may transition to advanced physical procedures when these measures fall short.